Skip to main content

 Related scientific articles (all)

The challenge of brain metastases from non-small cell lung cancer is not only an economical issue.

Authors : Martinive P, Van Houtte P
Year : 2019
Journal : Ann Palliat Med
Volume : 8
Pages : 203-206

A significant progress for non-small cell lung cancers : durvalumab consolidates radiochemotherapy in locally advanced stages - Une nouvelle avancée notable pour les cancers bronchiques non à petites cellules : le durvalumab consolide la radiochimiot

Authors : Moretti L, Charlier F
Year : 2019
Journal : Rev Med Brux
Volume : 40
Pages : 463-464

Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?

Authors : De Bruyn P, Van Gestel D, Ost P, Kruse V, Brochez L, Van Vlierberghe H, Devresse A, Del Marmol V, Le Moine A, Aspeslagh S
Year : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 54-64

Les cancers bronchiques non à petites cellules oligométastatiques: définition et prise en chargeOligometastatic non small cell lung cancers: Definition and management

Authors : Khalifa J, Brouchet L, Desmet A, Massabeau C, Van Houtte P
Year : 2019
Journal : Revue des Maladies Respiratoires Actualités.
Volume : 11(3)
Pages : 290-297

Paraganglioma of the head and neck region, treated with radiation therapy, a Rare Cancer Network study.

Authors : Lassen-Ramshad Y, Ozyar E, Alanyali S, Poortmans P, Van Houtte P, Sohawon S, Esassolak M, Krengli M, Villa S, Miller R, Demiroz C, Akyurek S, Aggerholm-Pedersen N, Thariat J
Year : 2019
Journal : Head Neck
Volume : 41
Pages : 1770-1776

Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study.

Authors : Larsen F, Terlizzi M, Linacre V, Sargos P, Suarez F, Kirova Y, Van Houtte P, Lerouge D, Zilli T, Sole CV
Year : 2019
Journal : Int J Radiat Oncol Biol Phys
Volume : 103
Pages : 1175-1181

Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients.

Authors : Dragan T, Beauvois S, Moreau M, Paesmans M, Vandekerkhove C, Cordier L, Van Gestel D
Year : 2019
Journal : Oral Oncol
Volume : 98
Pages : 132-140

PET and MRI based RT treatment planning: Handling uncertainties.

Authors : Reynaert N
Year : 2019
Journal : Cancer Radiother
Volume : 23
Pages : 753-760

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Authors : Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem G, Van Gestel D
Year : 2019
Journal : Cancers (Basel)
Volume : 11

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Authors : Levillain H, Duran Derijckere I, Ameye L, Guiot T, Braat A, Meyer C, Vanderlinden B, Reynaert N, Hendlisz A, Lam M, Deroose CM, Ahmadzadehfar H, Flamen P
Year : 2019
Journal : Eur J Nucl Med Mol Imaging
Volume : 46
Pages : 2270-2279

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.

Authors : Tuyaerts S, Van Nuffel AMT, Naert E, van Dam PA, Vuylsteke P, De Caluwe A, Aspeslagh S, Dirix P, Lippens L, De Jaeghere E, Amant F, Vandecasteele K, Denys H
Year : 2019
Journal : BMC Cancer
Volume : 19
Pages : 506

Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging.

Authors : Vanquin L, Boydev C, Korhonen J, Rault E, Crop F, Lacornerie T, Wagner A, Laffarguette J, Pasquier D, Reynaert N
Year : 2019
Journal : Cancer Radiother
Volume : 23
Pages : 281-289

Reply to Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas"."

Authors : Lassen-Ramshad Y, Ozyar E, Alanyali S, Poortmans P, Van Houtte P, Sohawon S, Esassolak M, Krengli M, Villa S, Miller RC, Demiroz C, Akyurek S, Aggerholm-Pedersen N, Thariat J
Year : 2019
Journal : Head Neck
Volume : 41
Pages : 2837-2838

Long-Term Clinical Outcome and Survivorship Issues of High Grade Bone Sarcomas

Authors : Closset C, Ameye L, Gebhart M, de Saint-Aubain de Somerhausen N, Beauvois S, Awada A, Piccart-Gebhart M, Gil T
Year : 2018
Journal : Int J cancer and oncology
Volume : 5(1)
Pages : 26-34

Quelles stratégies thérapeutiques pour les CBNPC oligo-métastatiques?

Authors : Desmet A, van Schil P, Van Houtte P
Year : 2018
Journal : Rev Mal Respir
Volume : 10
Pages : 326-331

On the conversion of dose to bone to dose to water in radiotherapy treatment planning systems

Authors : Reynaert N, Crop F, Sterpin E, Kawrakow I, Palmans H
Year : 2018
Journal : PHIRO
Volume : 5
Pages : 26-30

A dosimetry procedure for organs-at-risk in <sup>177</sup>Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.

Authors : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Reynaert N, Vandenberghe S, Flamen P
Year : 2018
Journal : Phys Med
Volume : 56
Pages : 41-49

Systemic treatments for thymoma and thymic carcinoma: A systematic review.

Authors : Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M, Girard N
Year : 2018
Journal : Lung Cancer
Volume : 126
Pages : 25-31

Shielding disk position in intra-operative electron radiotherapy (IOERT): A Monte Carlo study.

Authors : Alhamada H, Simon S, Philippson C, Vandekerkhove C, Jourani Y, Pauly N, Dubus A, Reynaert N
Year : 2018
Journal : Phys Med
Volume : 51
Pages : 1-6

90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.

Authors : Levillain H, Duran Derijckere I, Marin G, Guiot T, Vouche M, Reynaert N, Hendlisz A, Vanderlinden B, Flamen P
Year : 2018
Journal : EJNMMI Res
Volume : 8
Pages : 60